Legal Representation
Attorney
Talivaldis Cepuritis
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 6, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 25, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 31, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 11, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 15, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 13, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 13, 2002 | I | PAPER RECEIVED | Loading... | |
| Apr 4, 2002 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Mar 28, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 7, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 3, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jun 28, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR SCIENTIFIC OR RESEARCH USE
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
PHARMACEUTICAL PREPARATIONS FOR USE IN THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASES AND DISORDERS, NAMELY, CIRCULATORY, RESPIRATORY, ENDOCRINE, NEUROLOGIC, CARDIOVASCULAR, ALIMENTARY, ONCOLOGIC, AUTO-IMMUNE OR IMMUNE-RELATED, PULMONARY, MUSCULOSKELETAL, LYMPHATIC, GASTROINTESTINAL, BONE, SENSORY, VIRAL, URINARY, RENAL, INFECTIOUS, METABOLIC AND CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS; DIAGNOSTIC ASSAYS AND TEST KITS COMPRISED OF REAGENTS FOR CLINICAL AND MEDICAL LABORATORY USE TO DIAGNOSE, PROGNOSE, PREDICT AND TREAT DISEASES AND FOR PROVIDING GENOMIC AND PROTEOMIC PROFILES USEFUL IN THE SELECTION OF THERAPEUTICS; ASSAYS AND TEST KITS COMPRISED OF REAGENTS FOR EVALUATING EFFICACY OF TREATMENTS AND TREATMENT PROGRESS; PROGNOSTIC TEST KITS COMPRISED OF REAGENTS FOR IDENTIFYING HEREDITARY RISK FACTORS; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
RESEARCH AND DEVELOPMENT SERVICES RENDERED TO OTHERS FOR DISCOVERING SMALL-MOLECULE DRUGS, ANTIBODIES, ANTISENSE DRUGS, PEPTIDES, PROTEINS AND GENE THERAPY DRUGS; MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENTS BASED ON GENE AND PROTEIN EXPRESSION AND ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042